Gilead Sciences Overview
Gilead Sciences Target Price
Analysts' 12-month price predictions for GILD.
Share Price
$101.43
Average Target Price
$128.25
26.4% upside
26.4% upside4 analysts in the last 4 months
High: $132 | Low: $125
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-22 | Cantor FitzgeraldCarter Gould | $125 | 23.2% upside |  |
| 2025-03-11 | Morgan StanleyTerence Flynn | $130 | 28.2% upside | |
| 2025-03-05 | Johnson Rice | $126 | 24.2% upside | |
| 2025-03-04 | Oppenheimer | $132 | 30.1% upside | |
| 2025-01-07 | RBC CapitalBrian Abrahams | $83 |  18.2% downside | |
| 2024-11-07 | Piper SandlerJoseph Catanzaro | $105 | 3.5% upside | |
| 2024-10-21 | BMO CapitalEvan David Seigerman | $94 | 7.3% downside | |
| 2024-10-21 | Leerink PartnersAndrew Berens | $96 | 5.4% downside | |
| 2024-10-18 | Morgan StanleyTerence Flynn | $84 | 17.2% downside | |
| 2024-09-23 | JefferiesMichael Yee | $95 | 6.3% downside | |
| 2024-09-12 | Goldman SachsSalveen Richter | $71 | 30% downside | |
| 2024-09-12 | Morgan StanleyTerence Flynn | $79 | 22.1% downside | |
| 2024-09-11 | Piper SandlerJoseph Catanzaro | $95 | 6.3% downside | |
| 2024-08-14 | Truist FinancialAsthika Goonewardene | $83 | 18.2% downside | |
| 2024-08-09 | BMO CapitalEvan David Seigerman | $85 | 16.2% downside | |
| 2024-08-09 | RBC CapitalBrian Abrahams | $72 | 29% downside | |
| 2024-07-08 | Raymond JamesSteven Seedhouse | $93 | 8.3% downside | |
| 2024-06-24 | JefferiesMichael Yee | $85 | 16.2% downside | |
| 2024-06-20 | Robert W. BairdBrian Skorney | $80 | 21.1% downside | |
| 2024-06-17 | Mizuho SecuritiesSalim Syed | $90 | 11.3% downside | |
| 2024-06-14 | RBC CapitalBrian Abrahams | $74 | 27% downside | |
| 2024-05-20 | BMO CapitalEvan David Seigerman | $80 | 21.1% downside | |
| 2024-04-24 | HSBCMorten Herholdt | $69 | 32% downside | |
| 2024-02-14 | RBC CapitalBrian Abrahams | $76 | 25.1% downside | |
| 2023-09-27 | RBC CapitalBrian Abrahams | $84 | 17.2% downside | |
| 2023-09-08 | Bank of America SecuritiesGeoff Meacham | $95 | 6.3% downside | |
| 2023-02-03 | Leerink Partners | $91 | 10.3% downside | |
| 2023-02-03 | Piper Sandler | $112 | 10.4% upside | |
| 2023-01-03 | Wells Fargo | $90 | 11.3% downside | |
| 2022-12-01 | Morgan Stanley | $81 | 20.1% downside | |
| 2022-10-31 | BarclaysCarter Gould | $76 | 25.1% downside | |
| 2022-10-28 | Truist FinancialRobyn Karnauskas | $91 | 10.3% downside | |
| 2022-10-28 | Robert W. BairdBrian Skorney | $69 | 32% downside | |
| 2022-09-15 | Truist Financial | $76 | 25.1% downside | |
| 2022-09-13 | Wells Fargo | $74 | 27% downside | |
| 2022-07-15 | Morgan Stanley | $65 | 35.9% downside | |
| 2022-05-23 | Leerink PartnersDavid Risinger | $68 | 33% downside | |
| 2022-05-17 | Piper SandlerDo Kim | $69 | 32% downside | |
| 2022-04-29 | BMO Capital | $63 | 37.9% downside | |
| 2022-04-29 | Piper Sandler | $73 | 28% downside | |
| 2022-04-06 | Piper SandlerDo Kim | $71 | 30% downside | |
| 2022-03-31 | Wells FargoMohit Bansal | $63 | 37.9% downside | |
| 2022-03-01 | JefferiesMichael Yee | $80 | 21.1% downside | |
| 2022-02-24 | UBSColin Bristow | $54 | 46.8% downside | |
| 2022-02-24 | Morgan StanleyMatthew Harrison | $69 | 32% downside | |
| 2022-02-08 | Mizuho SecuritiesSalim Syed | $75 | 26.1% downside | |
| 2022-02-04 | Atlantic EquitiesSteve Chesney | $62 | 38.9% downside | |
| 2022-02-03 | Maxim GroupJason McCarthy | $84 | 17.2% downside | |
| 2022-02-03 | OppenheimerHartaj Singh | $90 | 11.3% downside | |
| 2022-01-28 | Argus ResearchDavid Toung | $75 | 26.1% downside | |